Valeas (Pharmaceuticals) Overview

  • Year Founded
  • 1934

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 84

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Valeas (Pharmaceuticals) General Information

Description

Operator of pharmaceutical company intended to dedicate energy and resource towards research and development. The company has developed in-depth know-how towards specific pathologies such as asthma, chronic obstructive bronchitis, retinopathies, upper and lower respiratory tract infections, anxiety, insomnia and depression and provides therapy for immunomodulatory, neuropsychiatric and otolaryngology, thereby ensuring treatment for various diseases.

Contact Information

Website
www.valeas.it
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Via Vallisneri, 10
  • 20133 Milan
  • Italy
+39 02
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • Via Vallisneri, 10
  • 20133 Milan
  • Italy
+39 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valeas (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Valeas (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Valeas (Pharmaceuticals) Patents

Valeas (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5721228-A Administering topically an effective amount of flunisolide or a flunisolide ester Inactive 20-Nov-1992
AU-5625194-A Rectal flunisolide compositions for treating inflammatory intestinal disorders Inactive 20-Nov-1992
CA-2149766-A1 Rectal flunisolide compositions for treating inflammatory intestinal disorders Active 20-Nov-1992
CA-2149766-C Rectal flunisolide compositions for treating inflammatory intestinal disorders Inactive 20-Nov-1992
EP-0804203-A1 Rectal flunisolide compositions for treating inflammatory intestinal disorders Active 20-Nov-1992 A61K9/02
To view Valeas (Pharmaceuticals)’s complete patent history, request access »

Valeas (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valeas (Pharmaceuticals) FAQs

  • When was Valeas (Pharmaceuticals) founded?

    Valeas (Pharmaceuticals) was founded in 1934.

  • Where is Valeas (Pharmaceuticals) headquartered?

    Valeas (Pharmaceuticals) is headquartered in Milan, Italy.

  • What is the size of Valeas (Pharmaceuticals)?

    Valeas (Pharmaceuticals) has 84 total employees.

  • What industry is Valeas (Pharmaceuticals) in?

    Valeas (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Valeas (Pharmaceuticals) a private or public company?

    Valeas (Pharmaceuticals) is a Private company.

  • What is Valeas (Pharmaceuticals)’s current revenue?

    The current revenue for Valeas (Pharmaceuticals) is .

  • When was Valeas (Pharmaceuticals) acquired?

    Valeas (Pharmaceuticals) was acquired on 25-Jul-2022.

  • Who acquired Valeas (Pharmaceuticals)?

    Valeas (Pharmaceuticals) was acquired by Neopharmed Gentili.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process